INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2010

High soy isoflavone intake was linked to a lower risk of breast cancer recurrence in postmenopausal patients on adjuvant endocrine therapy.

Researchers examined associations between baseline dietary intake of soy isoflavones, assessed via a food frequency questionnaire, and breast cancer recurrence and death among 524 patients over a median follow-up of 5.1 years. Among premenopausal patients, overall death rate was not related to soy isoflavone intake (HR 1.05, 95% CI 0.78-1.71 for >42.3 mg/day vs. <15.2 mg/day, p for trend = 0.87). In postmenopausal patients, the highest quartile of intake had a significantly lower risk of recurrence compared to the lowest quartile (HR 0.67, 95% CI 0.54-0.85, p for trend = 0.02), with inverse associations observed in estrogen and progesterone receptor-positive patients and those receiving anastrozole.

Shows an association, not proof of cause and effect.

Study type
Prospective cohort study
Who was studied
524 patients who underwent surgery for breast cancer and were receiving adjuvant endocrine therapy
What was measured
Recurrence of breast cancer and death

THE PAPER

Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy.

Kang X, Zhang Q, Wang S, Huang X, Jin S. CMAJ, 2010.

PubMed 20956506 ↗DOI 10.1503/cmaj.091298 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.